Suppr超能文献

相似文献

1
4,5-Dihydroxypyrimidine Methyl Carboxylates, Carboxylic Acids, and Carboxamides as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease.
J Med Chem. 2022 Apr 14;65(7):5830-5849. doi: 10.1021/acs.jmedchem.2c00203. Epub 2022 Apr 4.
2
8-Hydroxy-1,6-naphthyridine-7-carboxamides as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease.
ChemMedChem. 2022 Sep 5;17(17):e202200334. doi: 10.1002/cmdc.202200334. Epub 2022 Aug 10.
5
Hydroxypyridonecarboxylic Acids as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease.
ChemMedChem. 2018 Aug 20;13(16):1658-1663. doi: 10.1002/cmdc.201800283. Epub 2018 Jul 20.
6
Inhibition of Human Cytomegalovirus pUL89 Terminase Subunit Blocks Virus Replication and Genome Cleavage.
J Virol. 2017 Jan 18;91(3). doi: 10.1128/JVI.02152-16. Print 2017 Feb 1.
7
FRET-based assay using a three-way junction DNA substrate to identify inhibitors of human cytomegalovirus pUL89 endonuclease activity.
Eur J Pharm Sci. 2019 Jan 15;127:29-37. doi: 10.1016/j.ejps.2018.10.016. Epub 2018 Oct 17.
8
Inhibiting HCMV pUL89-C Endonuclease with Metal-Binding Compounds.
J Med Chem. 2023 Oct 26;66(20):13874-13887. doi: 10.1021/acs.jmedchem.3c01280. Epub 2023 Oct 12.
10
Metal-chelating 3-hydroxypyrimidine-2,4-diones inhibit human cytomegalovirus pUL89 endonuclease activity and virus replication.
Antiviral Res. 2018 Apr;152:10-17. doi: 10.1016/j.antiviral.2018.01.015. Epub 2018 Feb 6.

引用本文的文献

1
Inhibiting HCMV pUL89-C Endonuclease with Metal-Binding Compounds.
J Med Chem. 2023 Oct 26;66(20):13874-13887. doi: 10.1021/acs.jmedchem.3c01280. Epub 2023 Oct 12.
4
8-Hydroxy-1,6-naphthyridine-7-carboxamides as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease.
ChemMedChem. 2022 Sep 5;17(17):e202200334. doi: 10.1002/cmdc.202200334. Epub 2022 Aug 10.

本文引用的文献

1
FDA approves decades-old maribavir for CMV infection.
Nat Rev Drug Discov. 2022 Jan;21(1):9. doi: 10.1038/d41573-021-00208-2.
2
Hepatoselective Dihydroquinolizinone Bis-acids for HBsAg mRNA Degradation.
ACS Med Chem Lett. 2021 Jun 22;12(7):1130-1136. doi: 10.1021/acsmedchemlett.1c00228. eCollection 2021 Jul 8.
3
Ganciclovir therapeutic drug monitoring in transplant recipients.
J Antimicrob Chemother. 2021 Aug 12;76(9):2356-2363. doi: 10.1093/jac/dkab195.
5
Quinolinonyl Non-Diketo Acid Derivatives as Inhibitors of HIV-1 Ribonuclease H and Polymerase Functions of Reverse Transcriptase.
J Med Chem. 2021 Jun 24;64(12):8579-8598. doi: 10.1021/acs.jmedchem.1c00535. Epub 2021 Jun 9.
6
Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation.
Clin Microbiol Rev. 2020 Oct 28;34(1). doi: 10.1128/CMR.00043-19. Print 2020 Dec 16.
8
Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy.
Curr Hematol Malig Rep. 2020 Apr;15(2):90-102. doi: 10.1007/s11899-020-00557-6.
10
Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy.
BMC Infect Dis. 2019 Dec 4;19(1):1030. doi: 10.1186/s12879-019-4643-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验